Difference between revisions of "Inotuzumab ozogamicin (Besponsa)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
(package insert information) |
||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Antibody targeting CD22, conjugated with a cytotoxic, antitumor antibiotic (calicheamicin). Inotuzumab demonstrates a dose-dependent cytotoxicity both in vitro and in vivo. <ref>[http://clinicaltrials.gov/show/NCT01363297 ClinicalTrials.Gov website]</ref> | + | Class/mechanism: Antibody targeting CD22, conjugated with a cytotoxic, antitumor antibiotic (calicheamicin). Inotuzumab demonstrates a dose-dependent cytotoxicity both in vitro and in vivo. <ref name="insert">[http://labeling.pfizer.com/ShowLabeling.aspx?id=9503 Inotuzumab ozogamicin (Besponsa) package insert]</ref><ref>[[Media:Inotuzumabozogamicin.pdf | Inotuzumab ozogamicin (Besponsa) package insert (locally hosted backup)]]</ref><ref>[https://www.besponsa.com/ Besponsa manufacturer's website]</ref><ref>[http://clinicaltrials.gov/show/NCT01363297 ClinicalTrials.Gov website]</ref> |
<br>Route: IV | <br>Route: IV | ||
| − | <br>Extravasation: No information | + | <br>Extravasation: No information |
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information<ref name="insert"></ref>. |
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| Line 12: | Line 12: | ||
==Patient drug information== | ==Patient drug information== | ||
| − | + | *[http://www.chemocare.com/chemotherapy/drug-info/inotuzumab-ozogamicin.aspx Inotuzumab ozogamicin (Besponsa) patient drug information (Chemocare)]<ref>[http://www.chemocare.com/chemotherapy/drug-info/inotuzumab-ozogamicin.aspx Inotuzumab ozogamicin (Besponsa) patient drug information (Chemocare)]</ref> | |
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
Revision as of 05:56, 28 June 2018
General information
Class/mechanism: Antibody targeting CD22, conjugated with a cytotoxic, antitumor antibiotic (calicheamicin). Inotuzumab demonstrates a dose-dependent cytotoxicity both in vitro and in vivo. [1][2][3][4]
Route: IV
Extravasation: No information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information[1].
Diseases for which it is used
Patient drug information
History of changes in FDA indication
- 8/17/2017: FDA approved "for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)."
Also known as
- Code name: CMC-544
- Brand name: Besponsa